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This article provides a new view of the cellular mechanisms that have been proposed to explain the links between
infant formula feeding and the development of atopy and obesity. Epidemiological evidence points to an allergy- and
obesity-preventive effect of breastfeeding. Both allergy and obesity development have been traced back to accelerated
growth early in life. The nutrient-sensitive kinase mTORC1 is the master regulator of cell growth, which is predominantly
activated by amino acids. In contrast to breastfeeding, artificial infant formula feeding bears the risk of uncontrolled
excessive protein intake overactivating the infant’s mTORC1 signalling pathways. Overactivated mTORC1 enhances
S6K1-mediated adipocyte differentiation, but negatively regulates growth and differentiation of FoxP3+ regulatory
T-cells (Tregs), which are deficient in atopic individuals. Thus, the “early protein hypothesis” not only explains increased
mTORC1-mediated infant growth but also the development of mTORC1-driven diseases such as allergy and obesity
due to a postnatal deviation from the appropriate axis of mTORC1-driven metabolic and immunologic programming.
Remarkably, intake of fresh unpasteurized cow’s milk exhibits an allergy-preventive effect in farm children associated
with increased FoxP3+ Treg numbers. In contrast to unprocessed cow’s milk, formula lacks bioactive immune-regulatory
microRNAs, such as microRNA-155, which plays a major role in FoxP3 expression. Uncontrolled excessive protein supply
by formula feeding associated with the absence of bioactive microRNAs and bifidobacteria in formula apparently in a
synergistic way result in insufficient Treg maturation. Treg deficiency allows Th2-cell differentiation promoting the
development of allergic diseases. Formula-induced mTORC1 overactivation is thus the critical mechanism that explains
accelerated postnatal growth, allergy and obesity development on one aberrant pathway.
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Regulatory T-cellIntroduction
Allergy and obesity are common diseases of developed
countries. Epidemiological evidence points to an allergy-
preventive effect of breastfeeding [1,2]. The widespread
use of artificial infant formula feeding is the most recent
nutritional change introduced by industrialized societies
a century ago, a time when milk has been misinterpreted
as just food [3,4]. American paediatricians of the 1930’s
were convinced that it should be perfectly possible to pre-
pare an artificial formula that meets all the nutritional
requirements of a growing infant [3,4]. Notably, formula
feeding has been introduced straight into infant nutri-
tion without any prior knowledge of mechanistic target
of rapamycin complex 1 (mTORC1) signalling, a novelCorrespondence: melnik@t-online.de
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covery of the natural mTORC1-inhibitor rapamycin.
This immunosuppressive natural product of Strepto-
myces hygroscopicus was found on Easter Island (Rapa
Nui) and has been characterized in 1975 [5,6]. This
finding initiated modern mTOR biology that followed
45 years after the introduction of artificial formula
feeding in the 1930’s.
Based on translational research, this review links re-
cent insights into mTORC1 regulation to postnatal in-
fant growth and aberrant developmental programming
of the immune system and adipocyte differentiation.Review
mTORC1: the cell’s master regulator of cell growth
In the last decade, the nutrient-sensitive kinase mTORC1
has been extensively studied and appreciated as the cell’shis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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ation and autophagy [7-10]. mTORC1 senses multiple
internal and external signals such as cellular energy sta-
tus, the growth factors insulin and insulin-like growth
factor-1 (IGF-1), and most importantly amino acid avail-
ability [7-10]. mTORC1 is activated at the lysosomal
membrane in the presence of amino acids, especially by
leucine and glutamine, which play a predominant role for
mTORC1 activation [11-17]. Thus, there is a direct link
between amino acid availability and mTORC1-driven cell
growth.
Infant weight gain and allergy risk
The milk protein content of a mammalian species highly
correlates with its postnatal growth rate [18]. For in-
stance, rats with a milk protein concentration of approx.
11 g/dL double birth weight after 4 days, cats and dogs
with 8 to 9 g/dL after 10 days, cows with 3.5 g/dL after
40 days, and humans with 1.2 g/dL after 180 days, re-
spectively [18]. Thus, Homo sapiens exhibits the slowest
postnatal growth rate of all mammals, most likely repre-
senting an important privilege of evolution promoting
brain maturation and cognitive functions. Notably, rapid
weight gain in infancy has been linked to an increased
risk of asthma [19,20]. Lower birth weight (small for
gestational age) was associated with an increased risk of
asthma hospitalization in term children [21]. Notably,
increased postnatal catch-up growth in small for gesta-
tional age infants is associated with increased postnatal
mTORC1 signalling and increased childhood asthma
risk [22]. Moreover, excessive postnatal protein intake by
formula feeding increases weight gain, total body fat mass
and increases the risk of childhood obesity [23-25],
which has been linked to increased amino acid-mediated
mTORC1-signalling [26].
Epidemiological studies clearly confirm the intraindivi-
dual association between allergy and obesity [20,27-29].
Prospective cohort studies and two recently published
meta-analyses found an association between overweight,
especially obesity, and asthma in the appropriate tem-
poral sequence and in a dose–response manner [30].
Children with a pronounced weight gain slope in early life
were particularly at risk for asthma within the first 6 years
of life. The gain in body mass index (BMI) over time dur-
ing infancy thus appears to be a more important predictor
for asthma in childhood than excess weight at any specific
age (Figure 1) [30].
mTORC1 and T-cell activation
The metabolic demands of T-cells are extraordinary
[31]. Naïve T-cells are catabolic and exhibit low levels of
mTORC1 activity [32]. However, activation and effector
generation for both CD4+ and CD8+ T-cells results
in tremendous metabolic demands and a switch fromcatabolism to anabolism associated with an increase in
mTORC1 activity [32]. The immunosuppressive natural
mTOR-inhibitor rapamycin downregulates T-cell anabol-
ism and induces T-cell autophagy thereby suppressing
T-cell effector function [32]. The differentiation of helper
T-cells is regulated through the selective activation of
mTORC1 and mTORC2 [33]. Only mTORC1 integrates
environmental cues such as amino acids, energy, and
growth factors [32]. Amino acid abundance in the post-
natal period by excess protein intake due to artifical
formula feeding may thus overstimulate mTORC1 of
various immune cells. On the other hand, amino acid
deprivation inactivates mTORC1 and T-helper cell activity
and induces T-cell anergy [34,35]. Recent evidence con-
firms that mTORC1 signalling plays a critical role during
the early phases of allergic asthma [36,37], consistent with
studies showing a role for mTORC1 in early activation
and differentiation events of immune cells [33]. Thus, ex-
aggerated mTORC1 signalling by high protein formula
feeding may disturb early postnatal mTORC1-mediated
immune cell programming.
Insulin, IGF-1, AKT and regulatory T-cells
The amino acids leucine, glutamate, and isoleucine are
potent insulin secretagogues [38,39]. Excessive uptake of
amino acids by formula feeding explains enhanced insu-
lin secretion in comparison to breastfeeding [40-42].
Axelsson et al. [40] determined the urinary C-peptide
concentration, a measure of insulin secretion, in breastfed
versus formula-fed infants. Whereas breastfeeding exhib-
ited the lowest urinary C-peptide levels (2.2 ± 2.1 nmol/L),
feeding low protein formula (1.3 g protein/100 mL) re-
sulted in 32% increased C-peptide levels (2.9 ± 1.9 nmol/L).
Notably, high protein formula (1.8 g protein/100 mL) feed-
ing induced 218% elevated urinary C-peptide concentra-
tions (7.0 ± 4.8 nmol/L). Protein-dependent insulinotropic
effects of formula feeding have recently been confirmed by
a multicentre study of the European Childhood Obesity
Trial Study Group (Figure 2B) [41].
The insulinotropic amino acid leucine stimulates insu-
lin synthesis and insulin secretion of pancreatic β-cells
[38], and activates the translational regulators 4E-BP1
and the kinase S6K1 in an mTORC1-dependent manner
[43]. Furthermore, the glutaminolysis pathway plays a piv-
otal role for insulin secretion. In comparison to breast
milk, glutamate, the principal precursor of the glutamino-
lysis pathway [39], is increased by 60% in lower protein-
and 164% in higher protein infant formula [41]. Of key
regulatory function for the glutaminolysis pathway is the
enzyme glutamate dehydrogenase (GDH), which catalyses
the oxidative deamination of glutamate to α-ketoglutarate.
The later is a substrate of the Krebs cycle that generates
ATP required for insulin secretion. Notably, leucine acts as
an allosteric activator of GDH that contributes to leucine
Figure 1 Association between rapid weight gain in infancy and allergy and obesity development. The underlying mechanistic pathway
that may link these phenomena is exaggerated mTORC1 signalling.
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The combination of glutamine and leucine, which maxi-
mizes the flux through GDH, is most effective in phos-
phorylation of S6K1 in β-cells [43]. Taken together, leucine
and glutamine in a synergistic fashion activate mTORC1
promoting insulin synthesis and secretion of β-cells [46].
The majority of circulating IGF-1 is produced in the
liver (Figure 2). Insulin and amino acids independentlyFigure 2 Comparison of breast milk- and formula-mediated mTORC1
influx of milk proteins that after hydrolysis release leucine (Leu) and glutam
secretion, whereas casein-derived amino acids stimulate hepatic IGF-1 sy
inhibitory activity of the tuberin complex (TSC1-TSC2) towards RHEB, the
leucine uptake that activates the RAG GTPases, the essential step for mTORC
results in normal activation of the kinase S6K1 that controls adipocyte differe
protein uptake by infant formula feeding enhances plasma levels of leu
enhances adipocyte differentiation and inhibits FoxP3 expression, thus p
IR: Insulin receptor; IGF-1 insulin-like growth factor-1; IGF1R: IGF-1 recept
AKT: Akt kinase (protein kinase B); TSC1: Hamartin; TSC2: Tuberin; RHEB: RA
S6K1: Ribosomal protein S6 kinase, 70-KD.stimulate hepatic IGF-1 synthesis [47]. Amino acid avail-
ability of hepatocytes is essential for IGF-1 gene expression
[48]. In rat hepatocytes, amino acid excess increased IGF-1
expression [49]. In ovine hepatocytes, growth hormone
and amino acids synergistically enhanced IGF-1 produc-
tion. Thus, amino acid excess by formula feeding may
overstimulate hepatic IGF-1 synthesis. In fact, Socha et al.
[41] demonstrated that breastfeeding results in much lowersignalling. A. Human breast milk guarantees the appropriate intestinal
ine (Gln) into the circulation. Whey-derived leucine stimulates insulin
nthesis. Insulin and IGF-1 via PI3K activate AKT that attenuates the
GTPase that finally acivates mTORC1. Glutamine enhances cellular
1 activation at the lysosomal surface. Physiological mTORC1 activation
ntiation and adequate expression of FoxP3+ regulatory T-cells. B. Excess
cine, insulin and IGF-1 overactivating mTORC1. Overstimulated S6K1
romotes growth, obesity and allergy development. Abbreviations:
or; IRS-1: Insulin receptor substrate-1; PI3K: Phosphoinositiol-3 kinase;
S-homolog enriched in brain; RAG: RAS-related GTP-binding protein;
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ing. Infant formula with lower protein content (2.2 g pro-
tein/100 kcal) induced IGF-1 serum levels of 34.7 ng/mL
(+146%), whereas high protein formula (4.4 g protein/
100 kcal) raised IGF-1 serum concentrations to 48.4 ng/mL
(+243%) in infants at the age of 6 months. Furthermore,
increased plasma levels of insulin and IGF-1 have re-
cently been reported in formula-fed Rhesus monkeys that
received increased amounts of protein (1.83 g/dL) in com-
parison to Rhesus milk (1.16 g/dL) [42].
Taken together, high protein infant formula feeding
overstimulates insulin and IGF-1 production, which both
stimulate the downstream kinase AKT [50] that finally
activates mTORC1 (Figure 2) [7-10]. Intriguingly, AKT-
mediated phosphorylation of FoxO transcription factors
leads to their nuclear extrusion into the cytoplasm. Not-
ably, a FoxO3a-binding motif is present in the proximal
region of the Foxp3 promoter [51]. Both FoxO1 and
FoxO3a exert stimulatory effects on FoxP3 expression,
the key transcription factor of regulatory T-cells (Tregs)
[51]. There is convincing evidence that enhanced AKT-
mTORC1 signalling suppresses de novo differentiation of
FoxP3+ Tregs in the thymus [52,53]. In summary, exag-
gerated insulin/IGF-1 signalling, a characteristic endocrine
feature of recent formula feeding impairs Treg maturation.
Amino acids, mTORC1, and regulatory T-cells
Effector T-cell differentiation requires the integration of
multiple signals. Recent evidence underlines that mTOR
signalling dictates the outcome of Treg lineage commit-
ment [54]. Under normal activating conditions, T-cells
lacking mTOR differentiate into FoxP3+ Tregs [32,54].
Given that essential amino acids are important nutrient
signals activating mTORC1 [15-17], it could be expected
that amino acid abundance suppresses the differentiation
of Tregs. On the other hand, amino acid deprivation
should attenuate mTORC1 signalling. Indeed, Cobbold
et al. [35] demonstrated that T-cells failed to proliferate
in response to antigen, when one or more essential
amino acids were limited, which was associated with re-
duced mTORC1 signalling. Importantly, inhibition of
mTORC1 by limiting essential amino acids induced
FoxP3 expression [35]. There is convincing evidence
that the AKT-mTORC1 signalling axis negatively regu-
lates de novo differentiation of CD4+FoxP3+ Tregs in
the thymus [52,53]. Overactivated mTORC1 downregu-
lates the expression of FoxP3, the key transcription fac-
tor of Tregs [55]. In nasal polyps, whose association
with allergy is still controversial [56], significantly in-
creased infiltration of mTOR-activated inflammatory
cells and decreased infiltration of FoxP3+ Tregs have been
detected [57]. Excess protein intake by formula feeding
may thus overstimulate mTORC1 signalling compromis-
ing Treg differentiation. On the other hand, mTORC1activity is necessary to maintain Treg function partly
through inhibiting the mTORC2 pathway [58]. In mice,
TSC1 has been shown to play an important role in regulat-
ing thymic CD4+CD25+Foxp3+ nTreg-cell development via
a rapamycin-resistant and mTORC2-dependent signaling
pathway [59].
Regulatory T-cell deficiency in atopy
Tregs are essential for the maintenance of immune
homeostasis and inhibit the differentiation of Th2-cells,
suppress the production of IL-4, block the migration of
effector T-cells into inflamed tissue, suppress the produc-
tion of immunoglobulin E (IgE), induce IgG4 in B cells
and limit Th17-mediated inflammation [60,61]. Tregs
have been identified as key players that prevent allergy
development and are the target of immune therapy in the
treatment of allergic diseases [61-64]. Tregs are decreased
in plasma and sputum of asthma patients and plasma of
children with asthma, atopic dermatitis and food allergy
[65,66]. In atopic children, Treg deficiency was linearly re-
lated to increased IgE serum levels [65].
IL-4 increase in formula-fed Rhesus monkeys
Excessive protein intake with exaggerated mTORC1 sig-
nalling during a most vulnerable period of postnatal
Treg maturation may result in deficient Treg-mediated
suppression of Th2-cell differentiation increasing the
production of IL-4, the signature cytokine of Th2-driven
IgE responses. Intriguingly, formula-fed Rhesus monkeys,
that received excess amounts of protein (1.83 g/dL) in
comparison to Rhesus milk (1.16 g/dL) exhibited signifi-
cantly increased serum levels of IL-4 associated with accel-
erated growth in the first month of life [42].
Bifidobacteria and inducible regulatory T-cells
Tregs are not only generated in the thymus (nTregs),
but are also induced in the periphery (iTregs) such
as the intestine [58]. Formula feeding in comparison
to breastfeeding compromises the development of the
physiological gut microbiome. In breastfed Rhesus infants
Bifidobacteria and Lactobacillus predominated, whereas
in formula-fed infants Ruminococcus was predominant
[42]. Breastfed human infants harbor a fecal microbiota
more than twice increased in Bifidobacterium numbers
compared to formula-fed infants [67]. After formula feed-
ing, Atopobium was found in significant counts and the
numbers of Bifidobacteria dropped followed by increasing
numbers of Bacteroides population [67]. Remarkably,
breast milk is a natural source of bifidobacteria, which
play an important role for infant gut development and
maturation [68,69]. Complex oligosaccharides in breast
milk support the establishment of bifidobacteria in the
neonatal gut, which finally stimulate iTreg development
[70]. In fact, oral consumption of Bifidobacterium infantis
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human peripheral blood cells pointing to the immune-
stimulatory effect of bifidobacteria on FoxP3+ iTreg in-
duction [71,72]. It has recently been demonstrated that
bifidobacteria stimulate transforming growth factor-β
(TGFβ), which contributes to Treg differentiation [73].
Taken together, the probiotic effect of bifidobacteria in
the prevention of atopic diseases appears to be related to
their capability to generate FoxP3+ iTregs. In contrast,
infant formula, that lacks bifidobacteria, may impair ap-
propriate intestinal generation of FoxP3+ iTregs.
Immune-regulating microRNA deficiency in infant formula
Early-life consumption of unboiled cow’s milk has been
characterized in several studies of human infants to
be a protective factor for the development of atopy
[74-83]. Indeed, farm milk exposure has been associ-
ated with increased numbers of CD4+CD25+FoxP3+ Tregs,
lower atopic sensitization and asthma in 4.5-year-old
children [84].
The heat-sensitive atopy-preventive factor in fresh
unboiled cow’s milk has not yet been identified. Never-
theless, human and bovine milk contain substantial
amounts of exosomal microRNAs, which have been pos-
tulated to be involved in postnatal immune regulation
[85-90]. Milk microRNAs are transported by membran-
ous microvesicles, called exosomes that play a pivotal
role for horizontal microRNA transfer [91]. Raposo et al.
[92] provided first evidence for exosome-mediated im-
mune cell communication. Unidirectional transfer of
microRNA-loaded exosomes from T-cells to antigen-
presenting cells has recently been confirmed [93]. For im-
mune cell-cell interactions exosome transport exchanging
genetic messages over distances has been appreciated
[94,95]. Human and bovine milk contain high amounts of
exosomal microRNA-155 [86,87,96,97]. Admyre et al. [88]
showed that incubation of human peripheral blood mono-
nuclear cells with isolated human milk exosomes increased
the number of CD4+CD25+FoxP3+ Tregs in a dose-
dependent manner. Substantial evidence underlines that
the ancient immune-regulatory microRNA-155 is required
for the development of Tregs [98]. Notably, microRNA-
155-deficient mice have reduced numbers of Tregs both
in the thymus and in the periphery [98]. FoxP3 binds
to the promoter of bic, the gene encoding microRNA-
155 [99-101]. T-cell receptor (TCR) and Notch signal-
ling upregulate the IL-2R α-chain (CD25), rendering
thymocytes receptive to subsequent cytokine signals
that foster their development into fully functional
FoxP3+ Tregs [102-104]. IL-2 is capable of transducing
signals in CD4+FoxP3+ Tregs as determined by phos-
phorylation of signal transducer and activator of tran-
scription 5 (STAT5) [104]. Deletion of microRNA-155
results in limited IL-2/STAT5 signalling, which reducedTreg numbers [105]. Remarkably, microRNA-155 en-
hances FoxP3 expression by targeting suppressor of
cytokine signalling 1 (SOCS1), an important negative regu-
lator of IL-2R/STAT5 signalling [105].
Boiling of farm milk abolishes the atopy-preventive ef-
fect of cow’s milk [74-83]. Boiling of cow’s milk degrades
milk-derived bioactive microRNAs [90]. It has been
shown that exosome membrane integrity is essential for
the uptake of milk microRNAs into cultured cells [96].
The boiling process may disrupt the exosome lipid bi-
layer thus exposing the microRNA cargo to rapid RNase-
mediated degradation. These observations support the
recent concept that milk’s exosomal microRNAs may be
involved in the maturation of Tregs and provide a poten-
tial signalling network of fresh milk that controls ad-
equate maturation of Tregs preventing allergic immune
deviations [106]. Indeed, exosomes have been detected in
the intestine [107], and in the human and murine thymus
[108,109], where they induce Tregs [108]. It is thus con-
ceivable that during the postnatal period, a time with
higher intestinal permeability, immune-regulating exoso-
mal microRNAs may pass the intestinal permeability
barrier and traffic to the thymus or peripheral lympoid
organs to promote Treg maturation [110]. Whereas raw
unprocessed cow’s milk contains the highest amounts of
bioactive microRNAs of all known body fluids, pasteur-
ized milk contains much lower levels and milk powder
commonly used for infant formula production only ex-
hibits trace amounts of RNAs [86,87]. The absence of
bioactive microRNA-155 in infant formula may lead to
inappropriate intestinal or thymic Treg maturation pro-
viding a further argument for the allergy-promoting ef-
fect of formula feeding and for the atopy-preventive
effect of raw cow’s milk consumption early in life [106].
Breast milk n-3 polyunsaturated fatty acids and Treg
maturation
Maternal long-chain polyunsaturated fatty acid (LC-PUFA)
intake impacts their delivery to the infant either via the
placenta or breast milk [111]. Supplementation of preg-
nant women with n-3 PUFAs has been reported in some
studies to decrease sensitization to common food aller-
gens and to lower the prevalence and severity of atopic
dermatitis in the first year of life [112,113]. There appears
to be an effect of n-3 PUFAs in early life programming
of the immune system [114]. In a murine model of
cow’s milk allergy it could be demonstrated that allergy
prevention by n-3 LC-PUFA was mediated by the in-
duction of Tregs [115,116]. Yasuda et al. [117] recently
demonstrated that fatty acids have a profound impact
on mTORC1 regulation. Whereas the saturated fatty acid
palmitate activated mTORC1 by enhancing the trans-
location of mTORC1 to the lysosome, the unsaturated
n-3 fatty acid eicosapentaenoic acid inhibited saturated
Melnik Allergy, Asthma & Clinical Immunology 2014, 10:37 Page 6 of 10
http://www.aacijournal.com/content/10/1/37fatty acid-induced translocation of mTORC1 to the
lysosome and its subsequent activation [118]. n-3-fatty
acid-mediated attenuation of mTORC1 activity may thus
increase the maturation and function of Tregs. Breast
milk-derived n-3 LC-PUFAs may represent another milk-
derived control layer regulating Treg maturation.
Conclusions
Milk is the species-specific, genetically highly con-
served end product of lactation that ensures the ap-
propriate magnitude of mTORC1 activity of the milk
recipient, which plays a fundamental role in adipocyte
and Treg maturation [26,106,110]. The vector system
milk exhibits a hardware, primarily represented by essen-
tial branched-chain amino acids and glutamine for ap-
propriate mTORC1-dependent maturation of FoxP3+
Tregs [106,110]. Milk’s software appears to be repre-
sented by the delivery of exosomal immune-regulatory
microRNAs [85-90]. Especially the ancient microRNA-
155 appears to play a crucial role for FoxP3 expression
[98,105]. The relevance of iTregs to the development of
atopy in the first year of life is less clear. However, the
probiotic system of milk featured by milk-derived bifido-
bacteria regulates the appropriate development of the in-
fant’s gut microbiome by providing bifidobacteria as well
as bacterial nursing factors such as oligosaccharides of
human milk [118-121]. The appropriate composition of
milk fatty acids may have further impacts on mTORC1-
mediated Treg differentiation [115-117].
Thus, at least five interacting signalling networks of
milk control the induction of FoxP3 and Treg matur-
ation: 1) amino acid-mediated regulation of mTORC1,
2) milk exosomal microRNA-mediated FoxP3 expres-
sion, 3) milk-derived bifidobacteria and their growth-
promoting glycobiome, 4) fatty acid-mediated modulation
of mTORC1-dependent Treg maturation, and 5) the least
characterized role of milk-derived stem cells with the po-
tential of multilineage differentiation [122,123] (Table 1).
Mammalian lactation exhibits a highly sophisticated
growth-promoting, immune-regulating, and adipocyte
differentiating signalling network donated by mammaryTable 1 Effectors of postnatal feeding regulating FoxP3+ Treg
Effectors Mecha
Amount of protein influx (Excessive by formula feeding) Protein
that co
Exosomal microRNA (Absent in artificial formula) Exosom
microRN
Bifidobacteria (Absent in artificial formula) Breast m
bacteria
FoxP3+




expressglands secretory end product milk, which is obviously
not just food as misinterpreted in the early 1930’s [3,4].
At the molecular level, both the development of al-
lergy and childhood obesity can be traced back to exag-
gerated mTORC1 signalling during a vulnerable window
of postnatal programming. Accelerated postnatal growth
and weight gain just reflect overstimulated mTORC1
signalling during a sensitive period of human nutrition,
a period of life, in which the nutritional route is used
for lifelong metabolic and immunologic programming
(Figure 1).
The vigorous change from this evolutionarily developed
and genetically highly conserved system of breastfeeding
to an artificial programming procedure apparently repre-
sents the most serious error of modern medicine laying
the foundation for the worldwide epidemics of allergy and
obesity. This man-made disturbance of early mTORC1-
programming explains the comorbidity of allergy and
obesity.
It has to be kept in mind that not only the postnatal
period plays a fundamental role in metabolic and im-
munological programming but also fetal development
[124]. Maternal obesity has been related to fetal over-
growth and high birth weight. The later has been linked
to obesity and type 2-diabetes later in life [125,126]. In
contrast, rapid catch-up growth after intraunterine growth
restriction has been associated with the development of
asthma [21,127]. Placental nutrient transport is controlled
by insulin/IGF-1 and mTORC1 signalling and is up-
regulated in fetal overgrowth [128,129]. Notably, regu-
lar cow’s milk consumption increases both insulin/
IGF-1- and mTORC1 signalling [110]. It is thus not sur-
prising that milk consumption during pregnancy increased
fetal growth, infant size at birth and birth weight [130,131].
In terms of evolutionary biology, regular cow’s milk con-
sumption is a very recent behavorial change, which may
have adverse long-term health effects in humans [132].
During the last century, due to the implementation of
widespread cooling technology milk and other dairy prod-
ucts became alvailable on a large scale and cow’s milk-
based artificial infant feeding have been introduced intodifferentiation
nisms of FoxP3-induction
and amino acids regulate the magnitude of AKT- and mTORC1-activity
ntrols the expression of FoxP3.
al microRNA-155 enhances the expression of FoxP3, which promotes
A-155 expression.
ilk delivers bifidobacteria and milk-derived oligosaccharides that promote
l growth in the gut. Bifidobacteria induce intestinal generation of
iTregs.
yunsaturated fatty acids inhibit mTORC1 activation, thus promote FoxP3
ion, whereas saturated fatty acids activate mTORC1, thus attenuate FoxP3
ion.
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pregnancy and artificial infant feeding practices may
contribute to aberrant perinatal metabolic and im-
munologic programming. Future research has to clarify
which periods of perinatal life are most vulnerbale for
aberrations of nutritional mTORC1-mediated program-
ming. Rowe et al. [133] demonstrated that priming of
Th2 responses associated with persistent house dust mite
(HDM)-IgE production occurs entirely postnatally, as
HDM reactivity in cord blood seems nonspecific and was
unrelated to subsequent development of allergen-specific
Th2 memory or IgE. These observations underline the im-
portance of the postnatal period, which physiologically de-
pends on the programming effects of breastfeeding. Only
breastfeeding guarantees the species-specific mTORC1-
signalling axis controlled by the human lactation genome
that developed during millions of years of mammalian
evolution. After one century of formula feeding it is time
to remember the words of Dr Truby King who stated in
1913 in his book Feeding and Care of the Baby that the
natural food direct from the mother’s breast is the child’s
birth right [3,134].
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